Funding for this research was provided by:
China Tuberculosis Clinical Trial Consortium (2017KYJJ006)
Received: 10 September 2019
Accepted: 13 March 2020
First Online: 24 March 2020
Ethics approval and consent to participate
: This prospective study was approved by The Ethics Committee of the Shanghai Pulmonary Hospital (approval number: K19–148). Each participant gave written informed consent before enrollment.
: Not applicable.
: The authors declare that they have no competing interests.